Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression

Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 25(2013), 26 vom: 12. Juli, Seite 3532-41
1. Verfasser: Moore, Laura K (VerfasserIn)
Weitere Verfasser: Chow, Edward K, Osawa, Eiji, Bishop, J Michael, Ho, Dean
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2013
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. cancer drug delivery hybrid nanomaterials nanodiamond nanomedicine Antineoplastic Agents Lipids mehr... Nanodiamonds EGFR protein, human EC 2.7.10.1 ErbB Receptors
LEADER 01000naa a22002652 4500
001 NLM226666301
003 DE-627
005 20231224071930.0
007 cr uuu---uuuuu
008 231224s2013 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.201300343  |2 doi 
028 5 2 |a pubmed24n0755.xml 
035 |a (DE-627)NLM226666301 
035 |a (NLM)23584895 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Moore, Laura K  |e verfasserin  |4 aut 
245 1 0 |a Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression 
264 1 |c 2013 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 27.03.2014 
500 |a Date Revised 21.03.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
520 |a Self-assembled nanodiamond-lipid hybrid particles (NDLPs) harness the potent interaction between the nanodiamond (ND)-surface and small molecules, while providing a mechanism for cell-targeted imaging and therapy of triple negative breast cancers. Epidermal growth factor receptor-targeted NDLPs are highly biocompatible particles that provide cell-specific imaging, promote tumor retention of ND-complexes, prevent epirubicin toxicities and mediate regression of triple negative breast cancers 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Research Support, U.S. Gov't, Non-P.H.S. 
650 4 |a cancer 
650 4 |a drug delivery 
650 4 |a hybrid nanomaterials 
650 4 |a nanodiamond 
650 4 |a nanomedicine 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Lipids  |2 NLM 
650 7 |a Nanodiamonds  |2 NLM 
650 7 |a EGFR protein, human  |2 NLM 
650 7 |a EC 2.7.10.1  |2 NLM 
650 7 |a ErbB Receptors  |2 NLM 
650 7 |a EC 2.7.10.1  |2 NLM 
700 1 |a Chow, Edward K  |e verfasserin  |4 aut 
700 1 |a Osawa, Eiji  |e verfasserin  |4 aut 
700 1 |a Bishop, J Michael  |e verfasserin  |4 aut 
700 1 |a Ho, Dean  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 25(2013), 26 vom: 12. Juli, Seite 3532-41  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:25  |g year:2013  |g number:26  |g day:12  |g month:07  |g pages:3532-41 
856 4 0 |u http://dx.doi.org/10.1002/adma.201300343  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 25  |j 2013  |e 26  |b 12  |c 07  |h 3532-41